다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

JANX Janux Therapeutics Inc

47.62

-0.38 (-0.79%)

최종 업데이트: 23:56:24

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/27/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Andrew Hollman Meyer

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Janux Therapeutics (NASDAQ:JANX)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024

Janux Therapeutics 차트를 더 보려면 여기를 클릭.

Janux Therapeutics (NASDAQ:JANX)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024

Janux Therapeutics 차트를 더 보려면 여기를 클릭.

Janux Therapeutics Inc News

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies
0년 25월 11일, 2024 (2 일 전) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
0년 15월 11일, 2024 (2 주 전) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
0년 7월 11일, 2024 (3 주 전) • Edgar (US Regulatory)

Form 8-K - Current report
0년 7월 11일, 2024 (3 주 전) • Edgar (US Regulatory)

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
0년 7월 11일, 2024 (3 주 전) • Business Wire

Form 144 - Report of proposed sale of securities
0년 2월 11일, 2024 (4 주 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 2월 11일, 2024 (4 주 전) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
0년 31월 10일, 2024 (4 주 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 26월 10일, 2024 (1 월 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 26월 10일, 2024 (1 월 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 24월 10일, 2024 (1 월 전) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
0년 24월 10일, 2024 (1 월 전) • Edgar (US Regulatory)

More Janux Therapeutics Inc News Articles

BNP Paribas Issuance

Doman Building Materials

BlackRock Institutional ...

VanEck Vectors UCITS ETFs

BlackRock Institutional ...

Adva Optical Networking (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관